- Home
- GYRE vs MD Comparison
GYRE vs MD Comparison
Compare GYRE & MD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GYRE
- MD
- Stock Information
- Founded
- GYRE 2002
- MD 1979
- Country
- GYRE United States
- MD United States
- Employees
- GYRE N/A
- MD N/A
- Industry
- GYRE Biotechnology: Pharmaceutical Preparations
- MD Hospital/Nursing Management
- Sector
- GYRE Health Care
- MD Health Care
- Exchange
- GYRE Nasdaq
- MD Nasdaq
- Market Cap
- GYRE 1.3B
- MD 1.0B
- IPO Year
- GYRE N/A
- MD 1995
- Fundamental
- Price
- GYRE $11.42
- MD $14.46
- Analyst Decision
- GYRE
- MD Buy
- Analyst Count
- GYRE 0
- MD 7
- Target Price
- GYRE N/A
- MD $15.36
- AVG Volume (30 Days)
- GYRE 126.3K
- MD 644.8K
- Earning Date
- GYRE 11-13-2024
- MD 11-01-2024
- Dividend Yield
- GYRE N/A
- MD N/A
- EPS Growth
- GYRE N/A
- MD N/A
- EPS
- GYRE N/A
- MD N/A
- Revenue
- GYRE $105,033,000.00
- MD $2,006,998,000.00
- Revenue This Year
- GYRE $25.32
- MD $3.13
- Revenue Next Year
- GYRE $12.95
- MD N/A
- P/E Ratio
- GYRE N/A
- MD N/A
- Revenue Growth
- GYRE N/A
- MD N/A
- 52 Week Low
- GYRE $8.26
- MD $6.62
- 52 Week High
- GYRE $30.40
- MD $16.41
- Technical
- Relative Strength Index (RSI)
- GYRE 54.43
- MD 46.08
- Support Level
- GYRE $9.61
- MD $13.90
- Resistance Level
- GYRE $12.58
- MD $14.70
- Average True Range (ATR)
- GYRE 1.12
- MD 0.44
- MACD
- GYRE 0.16
- MD -0.12
- Stochastic Oscillator
- GYRE 79.51
- MD 21.67
About GYRE Gyre Therapeutics Inc.
Gyre Therapeutics Inc is a biopharmaceutical company headquartered in San Diego, CA, that is primarily focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis), formerly known as Nonalcoholic Steatohepatitis (NASH)) in the United States. In the United States, Hydronidone is currently being evaluated for the treatment of liver fibrosis across a broad spectrum of chronic liver diseases under an active Investigational New Drug (IND) application. Gyre is also advancing a diverse pipeline in China through a controlling interest in the Beijing Continent, including pirfenidone, F573, F528, and F230.
About MD Pediatrix Medical Group Inc.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment and generates majority of the revenue through neonatology and other pediatric subspecialties.